APOE and Alzheimer disease: Utilizing data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) studies, we hypothesized that elevated PP levels are associated with increased AD pathology and accelerated cognitive decline, particularly in APOE4 carriers.